Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 30, 2017

View Archived Issues

Celgene offers product and pipeline update for third quarter 2017

Bristol-Myers Squibb offers product and pipeline update from third quarter 2017

Mitobridge describes novel PPAR-delta agonists

JCR Pharmaceuticals to initiate development of JR-171 for Hurler Syndrome

Allergan presents new fMet-Leu-Phe receptor modulators

Boehringer Ingelheim discovers new orexin receptor type 1 antagonists

Novel proto-oncogene c-Ret inhibitors identified at Cancer Research Technology

DS-5010 demonstrates potent antitumor activity in vitro and in vivo

New antibacterials patented by Actelion Pharmaceuticals

FDA grants priority review to elagolix for endometriosis-associated pain

Successful tumor imagining with novel somatostatin receptor antagonist 68Ga-NODAGA-LM3

Fostemsavir reduces HIV-1 viral load in heavily treatment-experienced patients

Phase I trial to evaluate Curevac's immunomodulator CV-8102

Sumitomo Dainippon and Poxel sign strategic partnership for imeglimin in Asias countries

Merck & Co. withdraws European application for Keytruda in first-line metastatic non-squamous NSCLC

Novartis proposes to acquire Advanced Accelerator Applications

Argenx initiates phase I trial of subcutaneous formulation of ARGX-113

Clinical data for maralixibat in patients with Alagille syndrome presented

Janssen conducts phase 0 exploratory trial of [18F]MNI-1020 as imaging marker for tau protein

Reversible 18F-labeled tracer GEH200431-B a potential candidate for MAO-B imaging in humans

Rgenix releases preliminary phase Ia/b data on RGX-104 in advanced cancer

[Ga68]PSMA bimodal probe for radio- and fluorescence-guided surgery of prostate cancer

Longevity Biotech awarded grant to evaluate LBT-3627 for multiple sclerosis

New phase I study at Stanford explores CD19/CD22-CAR T cells for B-cell malignancies

Mereo agrees with AstraZeneca on exclusive license and option to acquire AZD-9668

New ATOM consortium aims to reduce preclinical cancer drug discovery time

Astellas establishes screening collaboration agreement with MMV for malaria

Daiichi Sankyo and Glycotope sign option agreement on ADC collaboration and licensing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...